Amblyomin-X, a recombinant Kunitz-type inhibitor, regulates cell adhesion and migration of human tumor cells
In a tumor microenvironment, endothelial cell migration and angiogenesis allow cancer to spread to other organs causing metastasis. Indeed, a number of molecules that are involved in cytoskeleton re-organization and intracellular signaling have been investigated for their effects on tumor cell grow...
Main Authors: | Mariana Costa Braga Schmidt, Katia L.P. Morais, Maíra Estanislau Soares de Almeida, Asif Iqbal, Mauricio Barbugiani Goldfeder, Ana Marisa Chudzinski-Tavassi |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | Cell Adhesion & Migration |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/19336918.2018.1516982 |
Similar Items
-
Structural and functional properties of the Kunitz-type and C-terminal domains of Amblyomin-X supporting its antitumor activity
by: K. L. P. Morais, et al.
Published: (2023-02-01) -
A Kunitz-type inhibitor from tick salivary glands: A promising novel antitumor drug candidate
by: Aline R. M. Lobba, et al.
Published: (2022-08-01) -
Editorial: The cytoskeleton in T cell migration and activation
by: Manish J. Butte, et al.
Published: (2022-10-01) -
Actin’ up: Herpesvirus Interactions with Rho GTPase Signaling
by: Herman W. Favoreel, et al.
Published: (2011-03-01) -
Preclinical evaluation of Amblyomin-X, a Kunitz-type protease inhibitor with antitumor activity
by: Durvanei A. Maria, et al.
Published: (2019-01-01)